Rukiye Ay

Dr. Rukiye Ay


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2017 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
MÇMerve Çukurova
Merve Çukurova
SBSevda Bağ
Sevda Bağ
SYSuat Yalçın
Suat Yalçın
CŞCansu Çakır Şen
Cansu Çakır Şen
ÇKÇağatay Karşıdağ
Çağatay Karşıdağ
ÖAÖznur Akıl
Öznur Akıl
(2017). 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology. Psychiatry and Clinical Psychopharmacology: Vol. 27, 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology Abstracts, pp. 85-180.

1 March 2018 in Psychiatry Research
Verified
Journal Article
Closed access
RARukiye Ay
Rukiye Ay
LELale Gonenir Erbay
Lale Gonenir Erbay

15 December 2016 in Archives of Neuropsychiatry
Verified
Journal Article
Closed access
RARukiye Ay
Rukiye Ay
OBOmer Boke
Omer Boke
OPOzan Pazvantoglu
Ozan Pazvantoglu
ASAhmet Rifat Sahin
Ahmet Rifat Sahin
GSGokhan Sarisoy
Gokhan Sarisoy
HGHatice Guz
Hatice Guz
Social cognition is a person's ability to configure the designs of relationships between themselves and others and to use these designs to guide social behaviors in a flexible manner. The models that are the most studied and describe social cognition are the theory of mind (ToM) and emotion recognition. This study was aimed to detect ToM and emotion recognition disorders in schizophrenia patients and their first-degree relatives. Thirty schizophrenia patients in remission, the first-degree relatives of schizophrenia patients (n=30), and 30 healthy volunteers who were paired with the patients in terms of age and duration of education were included in the study. The Positive and Negative Symptom Scale (PANSS), Dokuz-Eylül Theory of Mind Scale (DEToMS), Reading the Mind in the Eyes test, Facial Emotion Identification Test (FEIT), and Facial Emotion Discrimination Test (FEDT) were performed by the patients participating in this study. ToM and emotion recognition were found to be defective in the schizophrenia patients and their relatives. The performances of ToM and emotion recognition were ranked as the schizophrenia group, family group, and control group, from the worst to the best. The schizophrenia group showed poor performance in all sub-components except irony. In the family group, the empathy subcomponent showed similar performance with the control group, whereas the subcomponents of the second-order false belief, metaphor, and faux pas tests showed similar performance with the patient group. There were differences among the three groups in the first-order false belief subscale as well as the total DEToMS. The patient and family groups showed the poorest performances, whereas the control group showed the best performance. The detection of ToM and emotion recognition disorders in the remission period, regardless of the attack period and asymptomatic first-degree relatives, may support the view that the period of schizophrenia is an independent continuous variable.

30 September 2020 in Journal of Contemporary Medicine
Verified
Journal Article
Closed access
ŞKŞenay Kılınçel
Şenay Kılınçel
ZTZeynep Tuncer
Zeynep Tuncer
OKOğuzhan Kılınçel
Oğuzhan Kılınçel
EAEsma Akpınar Aslan
Esma Akpınar Aslan
RARukiye Ay
Rukiye Ay
CACengiz Akkaya
Cengiz Akkaya
Objective: We aimed to determine the effects of the COVID-19 outbreak on health workers' health concerns and life. Methods: The study included 293 healthcare professionals reached via e-mail. A questionnaire created by researchers and health anxiety inventory were applied online to all participants. The questionnaire questions investigated the sociodemographic characteristics of the participant, whether he received psychological support during the COVID-19 outbreak, whether he had a chronic disease, whether he had problems with the care of his children, whether he was actively involved in the COVID clinic / service, and how his social and work life was affected. Results: Participants consisted of 73 doctors, 145 nurses and 75 other healthcare professionals (OHP). It was determined that the COVID-19 test was performed to the healthcare personnel in the risk group at a very low rate (1.4%). The number of people receiving psychiatric support during the COVID-19 outbreak was 59 (20.1%). It was determined that the COVID-19 outbreak affected business life and social life of healthcare professionals very much and significantly (p

30 December 2020 in Journal of Contemporary Medicine
Verified
Journal Article
Closed access
PDF file
RARukiye Ay
Rukiye Ay
ŞKŞenay Kılınçel
Şenay Kılınçel
Giriş: Bu çalışmada aile hekimlerinin de dahil olduğu farklı branşlarda çalışan hekimlerin ; şiddete maruz kalmış kadınları tanıyabilmesi, tedavi ve korunmaları yönünde destek olabilmeleri için gerekli bilgi ve tutumlarını saptamak amaçlanmıştır. Gereç ve Yöntem: 250 gönüllü hekim çalışma kapsamına alındı.Tüm katılımcılara ‘Sosyodemografik ve klinik özellikler değerlendirme formu’ ve ‘Hemşire, ebe ve hekimlerin kadına yönelik şiddetin belirtilerini tanımalarına yönelik ölçek(alt ölçekleri duygusal belirtiler alt boyut /fiziksel belirtiler alt boyut) uygulandı Bulgular: İş yaşamında kadına yönelik şiddet olgusu/şüphesi ile karşılaşma oranı aile hekimlerinde istatistiksel olarak anlamlı derecede yüksek bulundu. Aile hekimi ve acil tıp hekimlerinde fiziksel belirtler alt boyut, duygusal belirtiler alt boyut ve toplam puanlar istatistiksel olarak anlamlı derecede düşük saptandı.Mezuniyet öncesi alınan eğitimler ölçek puanlarını etkilemezken; mezuniyet sonrasında alınan eğitimlerle ölçek puanlarında anlamlı düşme olduğu saptandı Sonuç: Bu çalışma bize hekimler için sık aralıklarla, pratiğe yönelik, kolay ulaşılabilir standart eğitimlerin düzenlenmesi ile kadına yönelik şiddet belirtilerini tanıma ve sonraki süreci yönetme konusunda bilgi düzeyi ve farkındalığın artırılmasının sağlanabileceğini düşündürmüştür.

5 May 2018 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
RARukiye Ay
Rukiye Ay
OAOzgur Aytas
Ozgur Aytas
Acneiform is used to describe eruptions that resemble acne vulgaris, but are not aetiologically similar. A number of drugs that can be responsible for acneiform eruptions exist. Vortioxetine is a multimodal antidepressant molecule that shows an antagonistic effect to the 5HT1D, 5HT3, and 5HT7 receptors, a partial agonistic effect to the 5HT1B receptor and a fully agonistic effect to the 5HT1A receptor, and also is an inhibitor to the serotonin transporter (SERT). In this article, we report a female patient who developed acneiform eruption during vortioxetine treatment.